Tobin Scientific: A Major Step in Life Sciences Growth
On May 7, 2025, Tobin Scientific, a recognized leader in the life sciences infrastructure sector, announced the closure of a significant capital investment totaling
$65 million. This funding aims to support the company's ambitious growth plan, further expanding its capabilities in cGMP storage, biorepository services, and specialized logistics essential for the biotechnology and pharmaceutical industries.
The new investment round was spearheaded by
Denali Growth Partners and
Truck 9 Partners, with significant financial backing from
Eastern Bank, which has provided a comprehensive financing package specifically designed to aid Tobin Scientific's growth initiatives. This capital will be allocated towards enhancing the company’s storage and logistics capacities, with a focus on expanding its footprint in major pharmaceutical hubs across the United States.
In today's rapidly evolving life sciences landscape, Tobin Scientific's commitment to meet the rising demand for intricate logistics solutions is evident. The funds will also be directed towards fostering mergers and acquisitions (M&A) initiatives aimed at optimizing the broader life sciences supply chain. Importantly, this capital raise represents a strategic investment without altering the company’s control; the current executive management team will remain in their respective roles, ensuring a seamless continuation of Tobin's operational vision.
According to Brian Tobin, the CEO, this milestone is a crucial moment for the company. “We’re building critical infrastructure to support our clients at every stage of the research and development lifecycle, from discovery through commercialization. Our partners share that vision, and this investment enables us to scale with confidence and purpose. This achievement is a testament to the expertise and commitment of our growing team to upholding the highest standards of service.”
With more than 365,000 square feet dedicated to both cold chain and ambient warehouse spaces, Tobin Scientific is committed to delivering specialized and reliable storage and transportation solutions tailored to the unique needs of its clients. The company's established reputation for its
white-glove service is a key differentiator in the competitive biopharma logistics market.
In a statement, Gregory Buscone, the Chief Commercial Banking Officer at Eastern Bank said, “We are pleased to provide this credit facility to support Tobin Scientific’s strategic growth initiatives. The company plays a vital role by enhancing critical infrastructure and specialized pharma services.”
Investors and industry experts alike are optimistic about the future of Tobin Scientific. Jesse Lane, Founder and Managing Partner of Denali Growth Partners, commented, “We are proud to invest in Tobin Scientific’s continued growth. The company’s strong track record and strategic vision emphasize its commitment to becoming a leading vertically integrated provider of services to the pharmaceutical industry.” He added, “Tobin Scientific’s ability to drive sustained revenue growth is a direct result of its unwavering focus on meeting customer needs with consistency and white-glove service.”
Alongside this investment, Stifel Financial Corp., under the leadership of Managing Director Tom Babich, acted as the exclusive financial advisor to Tobin Scientific throughout this transaction. Further details regarding the specific terms of the agreement have not been disclosed to the public.
For more information about Tobin Scientific, potential clients, and partners can visit their website at
TobinScientific.com to learn more about their extensive offerings, including laboratory relocations, compliance transportation, and cGMP warehousing solutions. In an era where precision and reliability are paramount for life sciences operations, Tobin Scientific is determined to be at the forefront of delivering essential logistics solutions that contribute to advancing the industry's landscape significantly.